Accelerate Diagnostics Ownership 2024 | Who Owns Accelerate Diagnostics Now?


OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

2.04%

Insider Ownership

43.59%

Retail Ownership

54.37%

Institutional Holders

2.00

Accelerate Diagnostics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BIRCHVIEW CAPITAL, LP2.23%0.26%325,239100,00044.40%321,986Mar 31, 2024
CHARTIST INC /CA/----68,996-100.00%-Mar 31, 2024

Accelerate Diagnostics's largest institutional shareholder is BIRCHVIEW CAPITAL, LP, holding 2.23% of the company's total share outstanding, currently valued at $321.99K. The top 10 institutional shareholders own together 2.23% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BIRCHVIEW CAPITAL, LP2.23%0.26%325,239100,00044.40%321,986Mar 31, 2024
CHARTIST INC /CA/----68,996-100.00%-Mar 31, 2024

The largest Accelerate Diagnostics shareholder by % of total assets is BIRCHVIEW CAPITAL, LP. The company owns 325.24K shares of Accelerate Diagnostics (AXDX), representing 0.26% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BIRCHVIEW CAPITAL, LP2.23%0.26%325,239100,00044.40%321,986Mar 31, 2024
CHARTIST INC /CA/----68,996-100.00%-Mar 31, 2024

As of Mar 31 2024, Accelerate Diagnostics's largest institutional buyer is BIRCHVIEW CAPITAL, LP. The company purchased 100.00K stocks of AXDX, valued at $321.99K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CHARTIST INC /CA/----68,996-100.00%-Mar 31, 2024
BIRCHVIEW CAPITAL, LP2.23%0.26%325,239100,00044.40%321,986Mar 31, 2024

As of Mar 31 2024, Accelerate Diagnostics's biggest institutional seller is CHARTIST INC /CA/. The company sold -69.00K shares of AXDX, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CHARTIST INC /CA/----68,996-100.00%-Mar 31, 2024

Accelerate Diagnostics's largest sold out institutional shareholder by shares sold is CHARTIST INC /CA/, sold -69.00K shares, valued at -, as of undefined.

Accelerate Diagnostics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
SPARROW FUNDS14.77%52,640--Feb 29, 2024
AMERICAN CENTURY GROWTH FUNDS, INC.0.15%22,653--Jan 31, 2024
MERIDIAN FUND INC0.12%415,312--Dec 29, 2023
VANGUARD VALLEY FORGE FUNDS0.11%53,242--Dec 31, 2023
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)0.02%164,900--Dec 31, 2023
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.02%91,026--Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%5,301--Dec 31, 2023
VANGUARD VALLEY FORGE FUNDS0.01%5,324--Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.01%52,110--Dec 31, 2023
VANGUARD EXPLORER FUND0.01%95,838--Jan 31, 2024
THOMPSON IM FUNDS INC0.01%113,900--Feb 29, 2024
VANGUARD INDEX FUNDS0.01%2,806,740--Dec 31, 2023
FIDELITY COMMONWEALTH TRUST0.01%18,427--Feb 29, 2024
BRIDGEWAY FUNDS INC0.01%13,800--Dec 29, 2023
Nushares ETF Trust0.01%38,759--Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 10.00%987--Dec 31, 2023
JNL VARIABLE FUND LLC0.00%21,420--Mar 31, 2020
Principal Exchange-Traded Funds0.00%43,438--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%461,544--Feb 29, 2024
Direxion Shares ETF Trust0.00%239,721--Jan 31, 2024
Fidelity Commonwealth Trust II0.00%9,510--Aug 31, 2023
VANGUARD HORIZON FUNDS0.00%26,425--Dec 31, 2023
Calvert Variable Products, Inc.0.00%2,287--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%25,335--Dec 31, 2023
VANGUARD INDEX FUNDS0.00%376,56280,12127.03%Dec 31, 2023
SCHWAB STRATEGIC TRUST0.00%150,621--Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%30,507--Feb 29, 2024
THOMPSON IM FUNDS INC0.00%10,390--Feb 29, 2024
Fidelity Rutland Square Trust II0.00%760,000--Feb 29, 2024
SunAmerica Specialty Series0.00%256--Apr 30, 2021
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%2,200--Dec 31, 2023
VANGUARD WORLD FUND0.00%109,142--Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.00%13,699--Dec 31, 2023
PFM Multi-Manager Series Trust0.00%300--Dec 31, 2023
TIAA-CREF LIFE FUNDS0.00%860--Dec 31, 2023
VANGUARD VARIABLE INSURANCE FUNDS0.00%12,377--Dec 31, 2023
FLEXSHARES TRUST0.00%15,225--Jan 31, 2024
HC CAPITAL TRUST0.00%5,000--Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%14,000--Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND0.00%136,370--Dec 31, 2023
FIDELITY SALEM STREET TRUST0.00%249,867--Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,361--Dec 31, 2023
RBB FUND, INC.0.00%8,811--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%26,380--Jan 31, 2024
ProFunds0.00%705--Jan 31, 2024
RYDEX SERIES FUNDS0.00%315--Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%981--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%112,767--Feb 29, 2024
SPDR INDEX SHARES FUNDS0.00%9,273--Dec 31, 2023
RYDEX DYNAMIC FUNDS0.00%173--Dec 31, 2023
VALIC Co I0.00%12,228--Feb 29, 2024
VANGUARD WELLINGTON FUND0.00%14,529--Feb 29, 2024
VANGUARD QUANTITATIVE FUNDS0.00%300--Dec 31, 2023
PENN SERIES FUNDS INC0.00%951--Dec 29, 2023
NATIONWIDE MUTUAL FUNDS0.00%4,421--Jan 31, 2024
Guggenheim Active Allocation Fund0.00%196--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%4,400--Dec 31, 2023
MASTER INVESTMENT PORTFOLIO0.00%2,436--Dec 31, 2023
RYDEX VARIABLE TRUST0.00%32--Dec 31, 2023
NORTHERN FUNDS0.00%17,790--Dec 29, 2023
PROSHARES TRUST0.00%4,761--Feb 29, 2024
ADVANCED SERIES TRUST0.00%76,200--Dec 29, 2023
ALLSPRING MASTER TRUST0.00%1,145--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,322--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%28,621--Dec 31, 2023
SPDR SERIES TRUST0.00%467,126--Dec 31, 2023
FIRST TRUST EXCHANGE-TRADED FUND0.00%92--Dec 31, 2023
SEI INSTITUTIONAL MANAGED TRUST0.00%25,262--Dec 31, 2023
Brighthouse Funds Trust II0.00%14,690--Dec 31, 2023
EQ ADVISORS TRUST0.00%6,320--Dec 31, 2023
PACIFIC SELECT FUND0.00%11,121--Dec 31, 2023
Advisors' Inner Circle Fund III0.00%46--Jan 31, 2024
MASSMUTUAL SELECT FUNDS0.00%2,969--Dec 31, 2023
iSHARES TRUST0.00%28,275--Feb 29, 2024
BlackRock Variable Series Funds, Inc.0.00%4,258--Dec 31, 2023
PRINCIPAL FUNDS, INC.0.00%6,407--Feb 29, 2024
Bridge Builder Trust0.00%4,134--Dec 31, 2023
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%1,152--Dec 31, 2023
BLACKROCK FUNDS0.00%3,064--Feb 29, 2024
John Hancock Funds II0.00%6,339--Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%4,900--Feb 29, 2024

Accelerate Diagnostics's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 52.64K shares, compromising 14.77% of its total assets.

Accelerate Diagnostics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Dec, 232-
30 Sep, 232-96.08%
30 Jun, 2351-26.09%
31 Mar, 2369-6.76%
31 Dec, 2274-8.64%
30 Sep, 228114.08%
30 Jun, 2271-32.38%
31 Mar, 221050.96%
31 Dec, 21104-0.95%
30 Sep, 2110510.53%
30 Jun, 2195-8.65%
31 Mar, 21104-12.61%
31 Dec, 201190.85%
30 Sep, 20118-10.61%
30 Jun, 2013214.78%
31 Mar, 20115-1.71%
31 Dec, 19117-3.31%
30 Sep, 19121-5.47%
30 Jun, 19128-
31 Mar, 191285.79%
31 Dec, 18121-8.33%
30 Sep, 181323.13%
30 Jun, 181282.40%
31 Mar, 18125-3.10%
31 Dec, 171293.20%
30 Sep, 17125-0.79%
30 Jun, 1712623.53%
31 Mar, 17102-9.73%
31 Dec, 161133.67%
30 Sep, 1610910.10%
30 Jun, 16997.61%
31 Mar, 1692-5.15%
31 Dec, 159711.49%
30 Sep, 15873.57%
30 Jun, 158416.67%
31 Mar, 1572-11.11%
31 Dec, 148110.96%
30 Sep, 1473-3.95%
30 Jun, 147633.33%
31 Mar, 145718.75%
31 Dec, 13489.09%
30 Sep, 13442.33%
30 Jun, 1343514.29%
31 Mar, 137-

As of 31 Dec 23, 2 institutions are holding Accelerate Diagnostics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Dec, 23294,2350.66%
30 Sep, 23292,312-98.67%
30 Jun, 2322,061,134-10.31%
31 Mar, 2324,595,869-3.23%
31 Dec, 2225,416,969-4.16%
30 Sep, 2226,519,69843.30%
30 Jun, 2218,506,887-18.67%
31 Mar, 2222,755,685-3.82%
31 Dec, 2123,658,3241.15%
30 Sep, 2123,390,170-2.37%
30 Jun, 2123,957,347-2.31%
31 Mar, 2124,523,020-11.58%
31 Dec, 2027,733,946-4.69%
30 Sep, 2029,097,354-0.53%
30 Jun, 2029,253,520-0.42%
31 Mar, 2029,377,311-2.10%
31 Dec, 1930,008,1871.97%
30 Sep, 1929,428,917-0.17%
30 Jun, 1929,479,4307.10%
31 Mar, 1927,526,163-0.39%
31 Dec, 1827,633,6355.40%
30 Sep, 1826,216,6626.65%
30 Jun, 1824,581,07117.07%
31 Mar, 1820,996,7540.94%
31 Dec, 1720,802,209-5.78%
30 Sep, 1722,079,19310.38%
30 Jun, 1720,002,245-1.19%
31 Mar, 1720,244,08433.85%
31 Dec, 1615,124,3475.58%
30 Sep, 1614,325,5575.88%
30 Jun, 1613,530,031-1.68%
31 Mar, 1613,761,7431.07%
31 Dec, 1513,615,85631.29%
30 Sep, 1510,370,7093.26%
30 Jun, 1510,043,59816.28%
31 Mar, 158,637,4139.46%
31 Dec, 147,890,85347.13%
30 Sep, 145,363,01012.20%
30 Jun, 144,779,969-46.14%
31 Mar, 148,874,882139.17%
31 Dec, 133,710,63614.41%
30 Sep, 133,243,31319.29%
30 Jun, 132,718,901215.15%
31 Mar, 13862,735-

Accelerate Diagnostics (AXDX) has 294.24K shares outstanding as of 31 Dec 23, up 0.66% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Dec, 232.04%0.29%
30 Sep, 2326.55%5.27%
30 Jun, 2322.44%3.58%
31 Mar, 2325.02%1.48%
31 Dec, 2241.18%4.43%
30 Sep, 2230.48%5.17%
30 Jun, 2224.28%2.15%
31 Mar, 2233.59%2.29%
31 Dec, 2138.33%2.62%
30 Sep, 2138.25%2.48%
30 Jun, 2139.24%2.23%
31 Mar, 2141.91%1.71%
31 Dec, 2049.52%1.87%
30 Sep, 2051.45%1.85%
30 Jun, 2052.76%1.84%
31 Mar, 2053.57%1.77%
31 Dec, 1955.05%1.89%
30 Sep, 1953.95%1.84%
30 Jun, 1954.11%2.11%
31 Mar, 1950.66%1.97%
31 Dec, 1850.71%2.16%
30 Sep, 1848.42%2.34%
30 Jun, 1845.52%3.20%
31 Mar, 1837.74%2.55%
31 Dec, 1738.47%2.41%
30 Sep, 1739.91%2.86%
30 Jun, 1737.34%2.45%
31 Mar, 1739.02%4.48%
31 Dec, 1629.50%3.77%
30 Sep, 1627.96%4.01%
30 Jun, 1626.42%3.66%
31 Mar, 1626.88%2.94%
31 Dec, 1530.26%5.63%
30 Sep, 1523.19%4.59%
30 Jun, 1522.48%6.01%
31 Mar, 1519.34%5.91%
31 Dec, 1418.09%12.50%
30 Sep, 1412.03%9.95%
30 Jun, 1410.99%2.44%
31 Mar, 1421.24%21.69%
31 Dec, 139.89%14.88%
30 Sep, 138.15%16.73%
30 Jun, 136.98%79.62%
31 Mar, 132.96%-

As of 31 Dec 23, Accelerate Diagnostics is held by 2.04% institutional shareholders, representing a 0.29% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Dec, 231-
30 Sep, 231-91.67%
30 Jun, 2312-45.45%
31 Mar, 2322-18.52%
31 Dec, 2227-25.00%
30 Sep, 223650.00%
30 Jun, 2224-44.19%
31 Mar, 2243-24.56%
31 Dec, 215729.55%
30 Sep, 214429.41%
30 Jun, 2134-12.82%
31 Mar, 2139-30.36%
31 Dec, 205647.37%
30 Sep, 2038-45.71%
30 Jun, 207048.94%
31 Mar, 204717.50%
31 Dec, 1940-20.00%
30 Sep, 1950-10.71%
30 Jun, 19567.69%
31 Mar, 195213.04%
31 Dec, 1846-9.80%
30 Sep, 1851-
30 Jun, 18518.51%
31 Mar, 1847-11.32%
31 Dec, 1753-17.19%
30 Sep, 1764-17.95%
30 Jun, 177847.17%
31 Mar, 1753-5.36%
31 Dec, 165614.29%
30 Sep, 164913.95%
30 Jun, 1643-30.65%
31 Mar, 16625.08%
31 Dec, 155931.11%
30 Sep, 154518.42%
30 Jun, 153815.15%
31 Mar, 1533-8.33%
31 Dec, 1436-5.26%
30 Sep, 1438-33.33%
30 Jun, 1457128.00%
31 Mar, 1425-21.88%
31 Dec, 133210.34%
30 Sep, 1329-21.62%
30 Jun, 1337428.57%
31 Mar, 137-

1 institutional shareholders have increased their position in AXDX stock as of 31 Dec 23 compared to 1 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Dec, 23--100.00%
30 Sep, 231-90.91%
30 Jun, 2311-21.43%
31 Mar, 2314-22.22%
31 Dec, 221820.00%
30 Sep, 2215-28.57%
30 Jun, 2221-30.00%
31 Mar, 223030.43%
31 Dec, 2123-30.30%
30 Sep, 21333.13%
30 Jun, 2132-17.95%
31 Mar, 213956.00%
31 Dec, 2025-30.56%
30 Sep, 203671.43%
30 Jun, 2021-25.00%
31 Mar, 2028-6.67%
31 Dec, 19307.14%
30 Sep, 192816.67%
30 Jun, 1924-20.00%
31 Mar, 1930-9.09%
31 Dec, 183313.79%
30 Sep, 1829-12.12%
30 Jun, 1833-2.94%
31 Mar, 1834-10.53%
31 Dec, 173872.73%
30 Sep, 172237.50%
30 Jun, 1716-33.33%
31 Mar, 1724-4.00%
31 Dec, 1625-16.67%
30 Sep, 16303.45%
30 Jun, 1629107.14%
31 Mar, 1614-12.50%
31 Dec, 1516-20.00%
30 Sep, 1520-23.08%
30 Jun, 152623.81%
31 Mar, 1521-22.22%
31 Dec, 142735.00%
30 Sep, 1420150.00%
30 Jun, 148-52.94%
31 Mar, 1417142.86%
31 Dec, 13716.67%
30 Sep, 136500.00%
30 Jun, 131-
31 Mar, 13--

- institutional shareholders have reduced their position in AXDX stock as of 31 Dec 23 compared to 1 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Dec, 232-294,2350.66%2.04%0.29%1---100.00%
30 Sep, 232-96.08%292,312-98.67%26.55%5.27%1-91.67%1-90.91%
30 Jun, 2351-26.09%22,061,134-10.31%22.44%3.58%12-45.45%11-21.43%
31 Mar, 2369-6.76%24,595,869-3.23%25.02%1.48%22-18.52%14-22.22%
31 Dec, 2274-8.64%25,416,969-4.16%41.18%4.43%27-25.00%1820.00%
30 Sep, 228114.08%26,519,69843.30%30.48%5.17%3650.00%15-28.57%
30 Jun, 2271-32.38%18,506,887-18.67%24.28%2.15%24-44.19%21-30.00%
31 Mar, 221050.96%22,755,685-3.82%33.59%2.29%43-24.56%3030.43%
31 Dec, 21104-0.95%23,658,3241.15%38.33%2.62%5729.55%23-30.30%
30 Sep, 2110510.53%23,390,170-2.37%38.25%2.48%4429.41%333.13%
30 Jun, 2195-8.65%23,957,347-2.31%39.24%2.23%34-12.82%32-17.95%
31 Mar, 21104-12.61%24,523,020-11.58%41.91%1.71%39-30.36%3956.00%
31 Dec, 201190.85%27,733,946-4.69%49.52%1.87%5647.37%25-30.56%
30 Sep, 20118-10.61%29,097,354-0.53%51.45%1.85%38-45.71%3671.43%
30 Jun, 2013214.78%29,253,520-0.42%52.76%1.84%7048.94%21-25.00%
31 Mar, 20115-1.71%29,377,311-2.10%53.57%1.77%4717.50%28-6.67%
31 Dec, 19117-3.31%30,008,1871.97%55.05%1.89%40-20.00%307.14%
30 Sep, 19121-5.47%29,428,917-0.17%53.95%1.84%50-10.71%2816.67%
30 Jun, 19128-29,479,4307.10%54.11%2.11%567.69%24-20.00%
31 Mar, 191285.79%27,526,163-0.39%50.66%1.97%5213.04%30-9.09%
31 Dec, 18121-8.33%27,633,6355.40%50.71%2.16%46-9.80%3313.79%
30 Sep, 181323.13%26,216,6626.65%48.42%2.34%51-29-12.12%
30 Jun, 181282.40%24,581,07117.07%45.52%3.20%518.51%33-2.94%
31 Mar, 18125-3.10%20,996,7540.94%37.74%2.55%47-11.32%34-10.53%
31 Dec, 171293.20%20,802,209-5.78%38.47%2.41%53-17.19%3872.73%
30 Sep, 17125-0.79%22,079,19310.38%39.91%2.86%64-17.95%2237.50%
30 Jun, 1712623.53%20,002,245-1.19%37.34%2.45%7847.17%16-33.33%
31 Mar, 17102-9.73%20,244,08433.85%39.02%4.48%53-5.36%24-4.00%
31 Dec, 161133.67%15,124,3475.58%29.50%3.77%5614.29%25-16.67%
30 Sep, 1610910.10%14,325,5575.88%27.96%4.01%4913.95%303.45%
30 Jun, 16997.61%13,530,031-1.68%26.42%3.66%43-30.65%29107.14%
31 Mar, 1692-5.15%13,761,7431.07%26.88%2.94%625.08%14-12.50%
31 Dec, 159711.49%13,615,85631.29%30.26%5.63%5931.11%16-20.00%
30 Sep, 15873.57%10,370,7093.26%23.19%4.59%4518.42%20-23.08%
30 Jun, 158416.67%10,043,59816.28%22.48%6.01%3815.15%2623.81%
31 Mar, 1572-11.11%8,637,4139.46%19.34%5.91%33-8.33%21-22.22%
31 Dec, 148110.96%7,890,85347.13%18.09%12.50%36-5.26%2735.00%
30 Sep, 1473-3.95%5,363,01012.20%12.03%9.95%38-33.33%20150.00%
30 Jun, 147633.33%4,779,969-46.14%10.99%2.44%57128.00%8-52.94%
31 Mar, 145718.75%8,874,882139.17%21.24%21.69%25-21.88%17142.86%
31 Dec, 13489.09%3,710,63614.41%9.89%14.88%3210.34%716.67%
30 Sep, 13442.33%3,243,31319.29%8.15%16.73%29-21.62%6500.00%
30 Jun, 1343514.29%2,718,901215.15%6.98%79.62%37428.57%1-
31 Mar, 137-862,735-2.96%-7---

Accelerate Diagnostics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 18, 2024Phillips Jackdirector, officer Chief Executive OfficerS-SaleSell26,735$0.78$20.85K162,919
Apr 16, 2024Phillips Jackdirector, officer Chief Executive OfficerS-SaleSell26,545$0.86$22.83K129,726
Apr 10, 2024Patience Davidofficer Chief Financial OfficerS-SaleSell13,296$0.87$11.57K50,419
Apr 10, 2024Mertz Larry Michaelofficer Chief Technology OfficerS-SaleSell13,984$0.87$12.17K81,106
Apr 05, 2024Mertz Larry Michaelofficer Chief Technology OfficerS-SaleSell978$0.88$860.6454,457
Apr 05, 2024Phillips Jackdirector, officer Chief Executive OfficerS-SaleSell15,887$0.88$13.98K96,343

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 18, 2024Phillips Jackdirector, officer Chief Executive OfficerS-SaleSell26,735$0.78$20.85K162,919
Apr 18, 2024Phillips Jackdirector, officer Chief Executive OfficerM-ExemptSell59,928---
Apr 16, 2024Phillips Jackdirector, officer Chief Executive OfficerS-SaleSell26,545$0.86$22.83K129,726
Apr 16, 2024Phillips Jackdirector, officer Chief Executive OfficerM-ExemptSell59,928--59,928
Apr 10, 2024Patience Davidofficer Chief Financial OfficerS-SaleSell13,296$0.87$11.57K50,419
Apr 10, 2024Patience Davidofficer Chief Financial OfficerM-ExemptSell37,468---
Apr 10, 2024Mertz Larry Michaelofficer Chief Technology OfficerS-SaleSell13,984$0.87$12.17K81,106
Apr 10, 2024Mertz Larry Michaelofficer Chief Technology OfficerM-ExemptSell40,633---
Apr 05, 2024Mertz Larry Michaelofficer Chief Technology OfficerS-SaleSell978$0.88$860.6454,457
Apr 05, 2024Mertz Larry Michaelofficer Chief Technology OfficerM-ExemptSell2,866--4,298
Apr 05, 2024Phillips Jackdirector, officer Chief Executive OfficerS-SaleSell15,887$0.88$13.98K96,343
Apr 05, 2024Phillips Jackdirector, officer Chief Executive OfficerM-ExemptSell35,523--53,283

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 18, 2024Phillips Jackdirector, officer Chief Executive OfficerM-ExemptBuy59,928--189,654
Apr 18, 2024Phillips Jackdirector, officer Chief Executive OfficerS-SaleSell26,735$0.78$20.85K162,919
Apr 18, 2024Phillips Jackdirector, officer Chief Executive OfficerM-ExemptSell59,928---
Apr 16, 2024Phillips Jackdirector, officer Chief Executive OfficerM-ExemptBuy59,928--156,271
Apr 16, 2024Phillips Jackdirector, officer Chief Executive OfficerS-SaleSell26,545$0.86$22.83K129,726
Apr 16, 2024Phillips Jackdirector, officer Chief Executive OfficerM-ExemptSell59,928--59,928
Apr 10, 2024Patience Davidofficer Chief Financial OfficerM-ExemptBuy37,468--63,715
Apr 10, 2024Patience Davidofficer Chief Financial OfficerS-SaleSell13,296$0.87$11.57K50,419
Apr 10, 2024Patience Davidofficer Chief Financial OfficerM-ExemptSell37,468---
Apr 10, 2024Mertz Larry Michaelofficer Chief Technology OfficerM-ExemptBuy40,633--95,090
Apr 10, 2024Mertz Larry Michaelofficer Chief Technology OfficerS-SaleSell13,984$0.87$12.17K81,106
Apr 10, 2024Mertz Larry Michaelofficer Chief Technology OfficerM-ExemptSell40,633---
Apr 05, 2024Mertz Larry Michaelofficer Chief Technology OfficerM-ExemptBuy2,866--55,435
Apr 05, 2024Mertz Larry Michaelofficer Chief Technology OfficerS-SaleSell978$0.88$860.6454,457
Apr 05, 2024Mertz Larry Michaelofficer Chief Technology OfficerM-ExemptSell2,866--4,298
Apr 05, 2024Phillips Jackdirector, officer Chief Executive OfficerM-ExemptBuy35,523--112,230
Apr 05, 2024Phillips Jackdirector, officer Chief Executive OfficerS-SaleSell15,887$0.88$13.98K96,343
Apr 05, 2024Phillips Jackdirector, officer Chief Executive OfficerM-ExemptSell35,523--53,283
Mar 06, 2024Patience Davidofficer Chief Financial OfficerA-AwardBuy37,468--37,468
Mar 06, 2024Mertz Larry Michaelofficer Chief Technology OfficerA-AwardBuy40,633--40,633

The last insider sell of Accelerate Diagnostics's stock was made by Phillips Jack on Apr 18 2024, selling 26,735 shares at $0.78 per share (valued at $20.85K).

Accelerate Diagnostics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202461250.00%
Q1 2024194475.00%
Q4 202351050.00%
Q3 202361250.00%
Q2 20234034117.65%
Q1 2023162176.19%
Q3 202292450.00%
Q2 20221611145.45%
Q1 2022102500.00%
Q4 202111--
Q3 202110--
Q2 2021228275.00%
Q1 2021178212.50%
Q4 20204850.00%
Q3 20203--
Q2 2020387542.86%
Q1 20202921450.00%
Q4 201911--
Q3 20198--
Q2 201912--

6 total buy trades, and 12 total sell trades (buy/sell ratio of 0.50%) were made by Accelerate Diagnostics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-6-
Q1 202482400.00%
Q4 2023-5-
Q3 2023-6-
Q2 2023-9-
Q1 2023-9-
Q3 20227--
Q2 20222450.00%
Q1 202261600.00%
Q4 202111--
Q3 20215--
Q2 2021-4-
Q1 20211425.00%
Q4 2020-4-
Q3 2020---
Q2 2020213700.00%
Q1 202011--
Q4 2019---
Q3 2019---
Q2 2019---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 6 open market sell trades of Accelerate Diagnostics's stocks.

Accelerate Diagnostics Peer Ownership


TickerCompany
IRMDIRadimed Corporation
ITGRInteger Holdings Corporation
AXGNAxoGen, Inc.
OFIXOrthofix Medical Inc.
AVNSAvanos Medical, Inc.
LIVNLivaNova PLC
SGHTSight Sciences, Inc.
NPCENeuroPace, Inc.
SRDXSurmodics, Inc.
LUNGPulmonx Corporation
OSAProSomnus, Inc. Common Stock
KIDSOrthoPediatrics Corp.
CNMDCONMED Corporation
CVRXCVRx, Inc.
ANIKAnika Therapeutics, Inc.
AORTArtivion, Inc.

AXDX Ownership FAQ


Accelerate Diagnostics is owned by institutional shareholders (2.04%), insiders (43.59%), and public (54.37%). The largest institutional shareholder of Accelerate Diagnostics is BIRCHVIEW CAPITAL, LP (2.23% of total shares) and the top mutual fund owner is SPARROW FUNDS (14.77% of total shares).

Accelerate Diagnostics's major institutional shareholders are BIRCHVIEW CAPITAL, LP, and CHARTIST INC /CA/. The top five shareholders own together 2.23% of the company's share outstanding.

As of Dec 2023, there are 2 institutional shareholders of Accelerate Diagnostics.

BIRCHVIEW CAPITAL, LP owns 325.24K shares of Accelerate Diagnostics, representing 2.23% of the company's total shares outstanding, valued at $321.99K (as of Mar 2024).

As of Mar 2024, CHARTIST INC /CA/ holds 0 shares of Accelerate Diagnostics (AXDX), compromising 0% of the company, valued at $0.